Departamento de Parasitologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil.
Centro de Pesquisa em Saúde Animal, Instituto de Pesquisas Veterinárias Desidério Finamor (IPVDF), Eldorado do Sul, Rio Grande do Sul, Brazil.
Exp Parasitol. 2020 Oct;217:107958. doi: 10.1016/j.exppara.2020.107958. Epub 2020 Jul 27.
Anaplasma marginale is the causative agent of the severe bovine anaplasmosis. The tick Rhipicephalus microplus is one of the main vectors of A. marginale in tropical and subtropical regions of the world. After the tick bite, the bacterium invades and proliferates within the bovine erythrocytes leading to anemia, impairment of milk production and weight loss. In addition, infection can cause abortion and high mortality in areas of enzootic instability. Immunization with live and inactivated vaccines are employed to control acute bovine anaplasmosis. However, they do not prevent persistent infection. Consequently, infected animals, even if immunized, are still reservoirs of the bacterium and contribute to its dissemination. Antimicrobials are largely employed for the prophylaxis of bovine anaplasmosis. However, they are often used in sublethal doses which may select pre-existing resistant bacteria and induce genetic or phenotypic variations. Therefore, we propose a new standardized in vitro assay to evaluate the susceptibility of A. marginale strains to different antimicrobials. This tool will help health professionals to choose the more adequate treatment for each herd which will prevent the selection and spread of resistant strains. For that, we initially evaluated the antimicrobial susceptibility of two field isolates of A. marginale (Jaboticabal and Palmeira) infecting bovines. The least susceptible strain (Jaboticabal) was used for the standardization of an antimicrobial assay using a culture of Ixodes scapularis-derived tick cell line, ISE6. Results showed that enrofloxacin (ENRO) at 0.25, 1 or 4 μg/mL and oxytetracycline (OTC) at 4 or 16 μg/mL are the most efficient treatments, followed by OTC at 1 μg/mL and imidocarb dipropionate (IMD) at 1 or 4 μg/mL. In addition, this proposed tool has technical advantages compared to the previously established bovine erythrocyte culture. Thereby, it may be used to guide cattle farmers to the correct use of antimicrobials. The choice of the most suitable antimicrobial is essential to eliminate persistent infections, prevent the spread of resistant strains and help controlling of bovine anaplasmosis.
边缘无浆体是严重牛无浆体病的病原体。在世界热带和亚热带地区,璃眼蜱(Rhipicephalus microplus)是边缘无浆体的主要传播媒介之一。蜱叮咬后,细菌在牛红细胞内入侵和增殖,导致贫血、产奶量下降和体重减轻。此外,感染可导致不稳定疫区的流产和高死亡率。使用活疫苗和灭活疫苗进行免疫接种可控制急性牛无浆体病。然而,它们并不能预防持续性感染。因此,即使免疫接种,受感染的动物仍然是细菌的储存库,并有助于其传播。抗生素主要用于预防牛无浆体病。然而,它们经常以亚致死剂量使用,这可能选择现有的耐药细菌并诱导遗传或表型变异。因此,我们提出了一种新的标准化体外检测方法来评估不同抗生素对边缘无浆体菌株的敏感性。该工具将帮助卫生专业人员为每个牛群选择更合适的治疗方法,从而防止耐药菌株的选择和传播。为此,我们首先评估了感染牛的两种田间分离株(Jaboticabal 和 Palmeira)的抗生素敏感性。最不敏感的菌株(Jaboticabal)用于使用来源于伊蚊(Ixodes scapularis)的 tick 细胞系 ISE6 的细菌培养物标准化抗生素检测。结果表明,恩诺沙星(ENRO)在 0.25、1 或 4μg/mL 和土霉素(OTC)在 4 或 16μg/mL 是最有效的治疗方法,其次是 OTC 在 1μg/mL 和咪唑苯脲二丙酸盐(IMD)在 1 或 4μg/mL。此外,与先前建立的牛红细胞培养相比,该工具具有技术优势。因此,它可用于指导牛农正确使用抗生素。选择最合适的抗生素对于消除持续性感染、防止耐药菌株的传播以及帮助控制牛无浆体病至关重要。